Syncom Healthcare, a Mumbai based Rs.85 crore plus healthcare company, has signed supply agreement with London-based Whyte International Ltd to market and distribute its range of products in various Latin American and European markets.
Whyte International is a part of £150 million UK based Whyte Group well known and well respected for its global sourcing services spread across Europe, Asia, the Middle East and Latin America.
The company is also providing services to Ranbaxy, Wockhardt, Glenmark, Lupin, Ajanta Pharma, Cadila Pharma, Emcure Pharma, Unichem Laboratories and Indoco Remedies.
Syncom Healthcare's sate of art WHO GMP approved manufacturing facility offers wide range of pharmaceutical formulations covering various therapeutic segments like GI, cardiovascular, diabetology, pain management, anti-infective, respiratory, etc. Its flagship brands like CTZ and FASTAC are leaders in their respective segments. The company also undertakes contract manufacturing for various pharma companies in India.